This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
ProAxsis presents its new NEATstik lateral flow test for lung infections at the Respiratory Professional Care Exhibition in Birmingham
ProAxsis, one of NetScientific’s portfolio companies specialized in the Life Sciences sector, has just presented its new NEATstik product which has been specially developed to make an immediate difference in respiratory management, at the UK’s Respiratory Professional Care Exhibition in Birmingham, 13th/14th October.
The ProAxsis Team welcomed over 400 people on to their stand over two days, and demonstrated how NEATstik, which is a unique Point-of-Care lateral flow test for monitoring active Neutrophil Elastase, a key biomarker of lung infection and inflammation in fresh sputum, can provide a much needed method for monitoring lung infections for further treatment. It has been created through the use of advanced patented Protease Tag technology by the company’s leading scientific expertise.